Induction of an Inhibitor of Influenza Virus Hemagglutination
|
|
- Polly Bradley
- 5 years ago
- Views:
Transcription
1 APPLIED MICROBIOLOGY, Apr. 1968, p American Society for Microbiology Vol. 16, No. 4 Printed in U.S.A. Induction of an Inhibitor of Influenza Virus Hemagglutination by Treatment of Serum with Periodate W. B. BEARDMORE, K. V. JONES, T. D. CLARK, AND E. K. HEBEKA Research Laboratories, Parke, Davis & Co., Detroit, Michigan Received for publication 3 January 1968 Serum is commonly treated with potassium periodate to destroy nonspecific inhibitors of influenza virus hemagglutination. We have observed, however, that such treatment of serum without pre-existing inhibitor produced high titers of inhibitor against certain strains of influenza virus. Inhibitor was induced in the serum from several different animal species but not in hamster or mouse serum. Periodate treatment of serum albumin, fraction V, from several animals, including man, creates this inhibitor. Our data indicate that the inhibitor induced in the serum of various animal species differs in its mechanism of induction and in its resistance to receptor-destroying enzyme and trypsin. Hemagglutination by B/Singapore/3/64, B/Colorado/2/ 65, B/Georgia/1 /65, and B/Massachusetts/3/66 strains of influenza virus is inhibited by periodate-treated human serum at dilutions as high as 1:5,120. The routine use of periodate treatment of serum in diagnostic and surveillance studies of influenza virus infections is not recommended. Certain strains of influenza virus are extremely sensitive to nonspecific,inhibitors in serum. These inhibitors cannot be removed by the use of heat, trypsin, or potassium periodate, individually or in combination, but they are reduced by receptordestroying enzyme (RDE) and are removed completely by treatment with dry ice (7). When we were preparing and testing standardized lots of B/Singapore/3/64 influenza virus seed and specific rooster antiserum, we observed the apparent induction of nonspecific inhibitor by treatment of the serum with potassium periodate. While this study was in progress, Mascoli et al. (6) reported a similar phenomenon with chicken and human serum with the 1965 influenza B viruses. The finding that periodate induces inhibitor is contrary to all other published studies on the elimination of nonspecific serum inhibitors. Potassium periodate has generally been considered to be an accepted method of removing nonspecific inhibitors (5). This report characterizes the induction and certain properties of this inhibitor. MATERIALS AND METHODS Viruses. All influenza virus strains used in this study were obtained from the Virus and Rickettsia Section of the National Communicable Disease Center, Atlanta, Ga. These seed viruses were passed in 10-day-old embryonated chicken eggs until satisfactory hemagglutination and infectivity titers were produced. The viruses either were stored frozen at C or lyophilized and stored at 4 C. Treatment of serum: Potassium periodate (). We mixed one volume of phosphate-buffered saline (PBS) and two volumes of serum and maintained these mixtures at 56 C for 30 min. Then we added six volumes of M and the mixture was held at room temperature for 15 min. Six volumes of 1% glycerol in distilled water was added, and the mixture was maintained at room temperature for an additional 15 min. The required dilution was then prepared with PBS. RDE (cholera filtrate). RDE (four volumes) containing 100 units/ml and one volume of serum were mixed and incubated overnight in a water bath at 37 C. Then, three volumes of 2.5% sodium citrate was added, and the mixture was held at 56 C for 30 min. The desired final dilution was prepared by the addition of PBS. Trypsin. We used a modification of the method described by Lennette and Schmidt (5). An amount of 0.5 ml of 0.1 M PBS, ph 7.2, containing 4 mg of tryp- 563 sin (Difco, 1:250), was added to 1.0 ml of serum at room temperature. This mixture was immediately placed in a 56 C water bath for 30 min, and PBS was then added to produce the desired final dilution. A fresh trypsin solution was prepared daily. Dry ice (CO2). Distilled water (0.8 ml) was mixed with 0.1 ml of serum previously heated at 56 C for 30 min. A small pellet of dry ice was then added to this serum. After activity ceased, the resulting precipitate was removed by centrifugation. An amount of 0.1 ml of 8.5% NaCl was added to the supernatant fluid; this made the 1:10 dilution from which the desired dilutions were prepared.
2 564 BEARDMORE ET AL. APPL. MICROBIOL. Kaolin. A 0.9-ml amount of a 20% suspension of acid-washed kaolin was added to 0.3 ml of serum, and the mixture was shaken every 5 min for 20 min. The kaolin was removed by centrifugation at 1,500 rev/min for 10 min. Hemagglutination-inhibition (HI) test. Twofold dilutions of serum, with PBS as diluent, were prepared; 0.25 ml was used in each tube. To each tube, 0.25 ml of virus containing four hemagglutination units was added, and the tubes were incubated at 37 C for 1 hr. A 0.5-ml amount of 5% human "O" erythrocytes was then added to each tube. The results were read after incubation at room temperature for 1 hr. RESULTS Table 1 summarizes our initial observations on the induction of inhibitor of B/Singapore/3/64 hemagglutination by treatment of heterologous influenza rooster antisera. Treatment with resulted in a 30- to 60-fold increase in hemagglutination titer over simple heat treatment of the serum. Since treatment utilizes KI04, glycerol, and heat, we attempted to determine which of these factors was responsible for the induction of the inhibitor. The results (Table 2) revealed that, of all the various procedures listed, heating the serum for 1 hr at 56 C followed by treatment produced the greatest titer of the inhibitor of B/Singapore/3/64 hemagglutination. The KI04 treatment had no detectable influence on homologous HI titer against A/Equine-2/Miami antigen. Glycerol alone, alone, and plus glycerol had no detectable effect on hemagglutination of B/Singapore/3/64 virus in the absence of serum. When the same A/Equine-2/Miami antiserum pool was treated by other common procedures (heating plus dry ice, heating plus RDE, and trypsin), no inhibitor was produced against B/ Singapore hemagglutination. Three different lots of KI04 were tested for their capacity to induce the inhibitor in normal TABLE 1. Induction of nonspecific inthibitor oj B/Singapore/3/64 influenza virus hemagglutination of human "0" erythrocytes by KI04 treatment ofheterologous rooster antiseruma Hemagglutina- Antiserum Serum treatment tion-inhibition treatment ~~ti ter A/WS/ C, 1 hr 1:80 A/WS/ :2,560 A/Equine-2/Miami.. 56 C, 1 hr 1:40 A/Equine-2/Miami... 1:2,560 a With all antisera used the antigen was B/Singapore. TABLE 2. Influence of heat, KI04, and glycerol on nonspecific inhibitor of B/Singapore influenza virus in A/Equine-2/Miami rooster antiserum Serum treatment Hemagglutination-inhibition titer A/Equine-2/ Miami antigen B/Singapore antigen Unheated :320 < 1: hr at 56C. 1: hr at 56 C... 1: hr at 56 C + (no glycerol). 1:320 1: 1, hr at 56 + glycerol (no ). 1: hr at 56 C + + glycerol :320 1:1,280 Unheated + KIO4. 1:320 1:320 Unheated + KIO4 + glycerol... 1:640 1:320 Unheated + glycerol. 1:320 chicken serum. All three lots gave identical results (Table 3). The influence of various concentrations of in the induction of inhibitor in normal chicken serum is also presented in Table 3. The concentrations that produced the highest titers were and M. We carried out a study to determine the effects of other procedures commonly used to destroy nonspecific inhibitors on normal chicken serum before and after treatment of the serum. The influence of such treatment on the final resulting titer of the inhibitor with B/Singapore as challenge virus is given in Table 4. Our salient observations showed that trypsin and RDE treatment of the serum before treatment prevented the induction of the inhibitor by, however, when applied after treatment, destruction of the inhibitor which was induced occurred. The site of action of the -induced inhibitor is unknown. We attempted to determine whether the inhibitor blocks hemagglutination by adsorption onto the virus particles or by adsorption onto the receptor sites on the surface of the erythrocytes. B/Singapore/3/64 influenza virus and a 1:160 dilution of -treated normal chicken serum were mixed together and incubated at 37 C for 30 min; the virus was removed by centrifugation in a Spinco ultracentrifuge. The HI activity of the adsorbed serum against B/ Singapore/3/64 virus was then determined. The results indicated that the B/Singapore/3/64 virus removed the -induced inhibitor from the serum (Table 5). To determine whether the inhibitor was adsorbed onto erythrocytes, 0.2 ml of normal
3 VOL. 16, 1968 INHIBITOR OF INFLUENZA VIRUS HEMAGGLUTINATION 565 TABLE 3. Induction of B/Singapore inhibitor with different lots and concentrations of Hemagglu- K1I4 concn (M) Lot no. and supplier tinationtiter , J. T. Baker Chemi- 1:640 cal Co., North Phillipsburg, N.J ,J. T. Baker Chemi- 1:640 cal Co , G. Frederick 1:640 Smith Chem, Columbus, Ohio , J. T. Baker Chem- 1: ,J. T. Baker Chem- 1: ,J. T. Baker Chem- 1: , J. T. Baker Chem- 1:40 None (heat 1:40 1 hr) Untreated TABLE 4. Effect of various treatments on periodateinduced inhibitor in normal chicken serum First Heat KIO4 Trypsin RDE Dry ice KI04 Kaolin KI04 Serum treatment Second Heat Trypsin KIO4 RDE Dry ice KI04 Kaolin Hemagglutinationinhibition titer 1:640 1:640 1:160 1:320 1:640 1:40 TABLE 5. Adsorption of KI04-induced inhibitor with B/Singapore/3/64 influenza virus chicken serum, treated with, was diluted to with PBS. A 10% suspension (2 ml) of human "O" cells was added to the serum and was incubated at 37 C for 1 hr. The cell-serum mixture was then centrifuged at 2,000 rev/min for 10 min, and the supernatant fluid was drawn off and discarded. A 0.5% suspension of the erythrocytes from the pellet was made and used in hemagglutination test with B/Singapore/3/64 influenza virus. A parallel test was run with untreated cells as a control. There was no evidence of adsorption of this inhibitor onto human "O" erythrocytes. A virus preparation had a hemagglutination titer of 1: 320 when tested with normal erythrocytes and eryth- ~~~Hemagglutina- ~~~~~~~~titer Normal chicken serum treatment Centrifugation tion-iniibition + virus... 1 hr at 30,000 rev/ <1:160 min Untreated + virus... 1 hr at 30,000 rev/ <1:160 (no min virus)... 1 hr at 30,000 rev/ 1:640 min (no virus)... None 1:640 Untreated... None < 1:160 rocytes previously treated with -processed serum. To establish whether the -induced inhibitor had any effect on the infectivity of a virus, doubling dilutions (1 :10 to 1:2,560) of periodatetreated normal chicken serum (which had an inhibitor titer against B/Singapore hemagglutination of 1:640) were incubated with an equal volume of B/Singapore virus (560 EIDo) for 1 hr at 37 C. Each of six 10-day-old embryonated chicken eggs was then inoculated in the allantoic sac with 0.2 ml of each dilution of the serum-virus mixture. The eggs were incubated at 35 C for 48 hr and refrigerated overnight; the allantoic fluid was harvested and tested for hemagglutination. All eggs were positive; this indicated that there was no inhibition of infectivity by the chicken serum before or after treatment even at a 1:10 dilution. Serum from eight adults and six children were tested to determine whether KI04 treatment induced inhibitor in human serum, as well as in chicken serum. The untreated sera had HI titers against B/Singapore virus of to 1:80. After treatment, the HI titer of all of the sera had increased to 1:1,280 to 1:2,560. Other strains of influenza virus reported to be very sensitive to nonspecific inhibitors (M. T. Coleman, Respiratory Virus Infections Unit, National Communicable Disease Center, personal communication) were also tested with - treated normal chicken and human sera (Table 6). treatment of all human and chicken serum induced an inhibitor against B/Colorado/2/65 and B/Georgia/i/65. An increase in the inhibitor of the B/Massachusetts/3/66 strain occurred in the treated human serum but not in the treated chicken serum. Normal chicken serum treated with did not inhibit hemagglutination by the following strains of influenza viruses: A/PR-8/34, Ai/
4 566 BEARDMORE ET AL. APPL. MICROBIOL. TABLE 6. Inhibition of different strains of influenza virus by KI04-treated chicken and human sera Serum no. Serum treatment Influenza virus strain Hemagglutination inhibition titer KI04-treated chicken serum B/Colorado/2/65 1:640 RDE-treated chicken serum B/Colorado/2/65 -treated chicken serum B/Georgia/1/65 1:320 RDE-treated chicken serum B/Georgia/l/65 < KI04-treated chicken serum B/Massachusetts/3/66 1:40 RDE-treated chicken serum B/Massachusetts/3/ C -treated children's serum B/Massachusetts/3/66 1: C Untreated children's serum B/Massachusetts/3/ C -treated children's serum B/Colorado/2/65 1:5, C Untreated children's serum B/Colorado/2/65 1: C -treated children's serum B/Georgia/1/65 1: C Untreated children's serum B/Georgia/l/65 1:80 44 A -treated adult human serum B/Massachusetts/3/66 1: A Untreated adult human serum B/Massachusetts/3/66 1:40 44 A KI04-treated adult human serum B/Colorado/2/65 1:5, A Untreated adult human serum B/Colorado/2/65 1: A -treated adult human serum B/Georgia/1/65 1:5, A Untreated adult human serum B/Georgia/l/65 1:160 TABLE 7. Influence of receptor-destroying enzyme (RDE) and trypsin treatment of human serum, before and after KI04 treatment, on the inhibition of B/Singapore/3/64 influenza virus hemagglutination Serum Untreated KI04 + RDE RDE + KIO KI04 + trypsin Trypsin + K14 Adult... 1:40 1:2,560 1:80 1:640 1:640 Adult... 1:80 1:1,280 1:80 1:1,280 1:5,120 1:2,560 Child... 1:2,560 1:40 1:80 1:640 1: 1,200 Child... 1:2,560 1:40 1:320 1:640 1:1,280 Child... 1:2,560 1:40 1:80 1:12,80 1:1,280 TABLE 8. Induction of inhibitor i) n serum from human adult and children's sera before and after various animal species treatment was examined. A summary of the influence of these treatmeats on inhibition of B/ Hemagglutination-i nhibition titer Singapore virus is given in Table 7. Apparently, Animal Human... Rabbit... Horse... Guinea pig... Rat... Chicken... Monkey. Fetal calf... Calf... Goat... Hamster... Mouse... Untreated 1:160 1:40 -treated RDE treatment before treatment of the serum permitted the induction of only low levels 1:2,560 of the inhibitor. RDE destroys almost all of the 1:1,280 KI04-induced inhibitor. In contrast, trypsin treat- 1:640 ment before or after K04 treatment has relatively 1:640 little effect. 1:640 Since both chicken and human serum developed 1:320 high titers of inhibitor to B/Singapore hemagglu- 1:160 tination after treatment, we tested serum 1:160 samples from several other animal species to 1:160 determine whether this same phenomenon would 1:80 occur. There was great variation among these different sera in their capacity to form inhibitor <* 20 as a result of KI04 treatment. The spectrum ranged from human serum, which consistently FM-1 /47, A/Swine/31, A2/Japan /170/62, A2/ showed the greatest increase in inhibitor, to Japan/305/57, B/Maryland/i /59, B/Taiwan/2/ hamster and mouse serum, neither of which 62, and B/Lee/40. demonstrated a detectable increase in inhibitor The effect of RDE and trypsin treatment of (Table 8).
5 VOL. 16, 1968 INHIBITOR OF INFLUENZA VIRUS HEMAGGLUTINATION 567 In an effort to determine which human serum substrate the periodate converted to inhibitor, preparations of serum albumin (1:10) and -yglobulin (1:100) were titrated for inhibitor after periodate treatment and after RDE treatment. There was no detectable inhibitor induced in the albumin or y-globulin after RDE treatment. However, after periodate treatment, the -y-globulin was not inhibitory, but the serum albumin inhibited B/Singapore virus hemagglutination at 1:640. This suggested that the -converted serum albumin into a hemagglutinationinhibitor. The concentration of serum albumin normally found in human serum is 35 mg/ml; therefore, to determine the influence of the concentration on the titer of the -induced inhibitor, we treated a series of dilutions of serum albumin with (Table 9). The results demonstrated that the treatment of higher concentrations of serum albumin with produced higher titers of the inhibitor; but, at normal serum levels, an inhibitor with a titer of only 1:80 was induced. These data suggest that another component or components of serum may be acted upon by to induce the usually observed titer of 1:1,280. The serum albumin from representative animal species whose serum showed high or poor capacity to produce inhibitor by treatment was tested at a concentration of 35 mg/ml before and after treatment. The titers of B/Singapore TABLE 9. Induction of inhibitor by treatment of various concentrations of human serum albumin, fraction V Concn of albumin Hemagglutination-inhibition titer mg/ml 20 1: : : :1,280 TABLE 10. inhibitor that were induced are summarized in Table 10. Human and chicken serum albumin showed an increase in inhibitor, and the sera from both of these species demonstrated a considerable increase in inhibitor titer after treatment (Table 8). Mouse serum albumin did not have any detectable inhibition of hemagglutination before or after treatment. Apparently treatment of mouse serum did not induce any detectable inhibitor (Table 8). The correlation between the induction of inhibitor in serum and serum albumin nevertheless breaks down; in the case of the horse and bovine serum albumin, however, in which no inhibitor was induced, both sera showed a great increase in inhibitor after treatment. These data suggest that more than one component of serum may be converted into inhibitor, and this may vary from one species to another. DISCUSSION The induction of an inhibitor of influenza virus hemagglutination by treatment of mucoids with has been recognized for a long time. In 1948, Burnet (1, 2) reported that purified cyst mucoid, which in the unmodified state has very little inhibiting effect on the A/W SE strain of influenza virus, could be converted into a strong inhibitor of the virus by treatment with periodate. Other similar investigations on other purified or semipurified mucoids were subsequently published (3, 4). The inhibitor induced by periodate treatment of serum differs from the inhibitor described by Burnet. He found that a sharply defined level of periodate was required to convert cyst mucoid into an active inhibitor of virus hemagglutination and that when this critical concentration was doubled it destroyed the inhibitor. The concentration of periodate required for the induction of inhibitor in serum is not critical, and doubling the optimum concentration does not destroy the Induction of inhibitor by KI04 treatment of serum albumin, fraction V, from various animal species Animal Serum supplier Jiemagglutination- inhibition titer Untreated K IO-treated Human Nutritional Biochemicals Corp., Cleve- 1:80 land, Ohio Chicken Nutritional Biochemicals Corp. < 1:80 Bovine Armour Pharmaceut, Kankakee, Ill. Horse... Nutritional Biochemicals Corp. < Mouse... Pentex, Inc., Kankakee, 111. < <
6 568 BEARDMORE ET AL. APPL. MICROBIOL. inhibitor (Table 3). Burnet also showed that the inhibitor created from mucoproteins prevented infection by influenza virus, as well as inhibiting hemagglutination of erythrocytes. The inhibitor created by treatment of serum with periodate does not have any detectable influence on the infectivity of B/Singapore/3/64 influenza virus, although it strongly inhibits viral hemagglutination. Possibly, the inhibitor-coated virus either enters into chicken embryo cells where the complex is broken, and the virus particles initiate infection or, perhaps, dissociation of the inhibitor occurs at the cell membrane. Aside from the unusual method of creation of this inhibitor, it has many characteristics in common with other well-known serum inhibitors. This inhibitor occurs in the serum of a variety of animal species and is destroyed by conventional methods used to remove nonspecific inhibitors, e.g., RDE and trypsin. The action of the inhibitor appears to be on the virus rather than on the erythrocyte surface. The components of serum which are converted by periodate into this inhibitor are unknown, although our data suggest that serum albumin of humans and certain animals plays some role. The mechanism of inhibitor creation may differ from one animal species to another for the following reasons. (i) RDE treatment of both normal chicken and human sera before treatment blocks the formation of the inhibitor. RDE also destroys the induced inhibitor. Trypsin has the same effect on chicken serum but has relatively little effect on human serum. (ii) Periodate treatment of normal chicken serum does not induce inhibitor against B/Massachusetts/3/66 influenza virus, although the same treatment of human serum does induce a high titer of inhibitor against this virus. (iii) Serum from a variety of relatively unrelated animal species, such as man, rabbits, horse, guinea pig, rat, and chicken, produces high titers of an inhibitor to B/Singapore influenza virus hemagglutination following KI04 treatment. No inhibitor is produced by the same treatment of the sera from the hamster and mouse. (iv) Periodate treatment of serum albumin, fraction V, from humans and chickens (both of which show induction of serum inhibitor by ) induces inhibitor, but periodate treatment of serum albumin, fraction V, of cows and horses (which also show induction of serum inhibitor by ) does not induce inhibitor. An immediate practical application of these findings would appear to be the invalidation of the routine periodate treatment of serum to remove nonspecific inhibitors of influenza virus in surveillance and diagnostic studies. One strain of influenza virus isolated in 1964, two strains isolated in 1965, and one strain isolated in 1966 were found to be strongly inhibited by this periodate-induced inhibitor. All of the viruses are B strains, but the sensitivity of all future isolates to this inhibitor would have to be determined before periodate heat treatment of human or animal serum could be utilized. ACKNOWLEDGMENT This study was conducted under contract PH with the Research Reference Reagents Branch of the National Institute of Allergy and Infectious Diseases. LITERATURE CITED 1. BURNET, F. M Mucins and mucoids in relation to influenza virus action. Inhibition by purified mucoid of infection and haemagglutination with the virus strain WSE. Australian J. Exptl. Biol. Med. Sci. 26: BURNET, F. M Mucins and mucoids in relation to influenza virus action. The destruction of "Francis Inhibitor" activity in a purified mucoid by virus action. Australian J. Exptl. Biol. Med. Sci. 26: BURNET, F. M The effect of periodate on the virus-inhibiting qualities of mucoids in solution. Australian J. Exptl. Biol. Med. Sci. 27: BURNET, F. M Mucoproteins in relation to virus action. Phys. Rev. 31: LENNEFFE, E. H., AND N. J. SCHMIDT Diagnostic procedures for viral and rickettsial diseases, 3rd ed., p. 38. American Public Health Association, Inc., New York. 6. MASCOLI, C. C., M. B. LEoGus, AND M. R. HILLE- MAN Influenza B in the Spring of Proc. Soc. Exptl. Biol. Med. 123: ROBINSON, R. Q Communicable Disease Center Influenza-Respiratory Disease Surveillance Report No. 81 IV, Laboratory Rept. 21. National Communicable Disease Center, Atlanta, Ga.
however, and the present communication is concerned with some of
THE AGGLUTINATION OF HUMAN ERYTHROCYTES MODIFIED BY TREATMENT WITH NEWCASTLE DISEASE AND INFLUENZA VIRUS' ALFRED L. FLORMAN' Pediatric Service and Division of Bacteriology, The Mount Sinai Hospital, New
More informationUse of Trypsin-Modified Human Erythrocytes
APPLIED MICROBIOLOGY, Sept. 1972, p. 353-357 Copyright i 1972 American Society for Microbiology Vol. 24, No. 3 Printed in U.S.A. Use of Trypsin-Modified Human Erythrocytes in Rubella Hemagglutination-Inhibition
More informationNOTES CONTAMINATION OF CYNOMOLGUS MONKEY KIDNEY CELL CULTURES BY HEMAGGLUTINATING SIMIAN VIRUS (SV 5)
Japan. J. Med. Sci. Biol., 18, 151-156, 1965 NOTES CONTAMINATION OF CYNOMOLGUS MONKEY KIDNEY CELL CULTURES BY HEMAGGLUTINATING SIMIAN VIRUS (SV 5) Since the extensive use of cynomolgus monkey kidney cell
More informationEffect of Complement and Viral Filtration on the
APPLIED MICROBIOLOGY, JUlY 1968, p. 1076-1080 Copyright @ 1968 American Society for Microbiology Vol. 16, No. 7 Printed in U.S.A. Effect of Complement and Viral Filtration on the Neutralization of Respiratory
More informationIntroduction.-Cytopathogenic viruses may lose their cell-destroying capacity
AN INHIBITOR OF VIRAL ACTIVITY APPEARING IN INFECTED CELL CULTURES* BY MONTO Hot AND JOHN F. ENDERS RESEARCH DIVISION OF INFECTIOUS DISEASES, THE CHILDREN'S MEDICAL CENTER, AND THE DEPARTMENT OF BACTERIOLOGY
More informationUltraviolet Light Upon Influenza Virus Infectivity,
APPuED MICROBIOLOGY, Feb. 197, p. 29-294 Copyright @ 197 American Society for Microbiology Vol. 19, No. 2 Printed in U.S.A. Effect of Formalin, 3-Propiolactone, Merthiolate, and Ultraviolet Light Upon
More informationAntigenicity of Influenza Vaccine from Bovine Cell Cultures
APPLIED MICROBIOLOGY, Oct. 1969, p. 596-600 Copyright 1969 American Society for Microbiology Vol. 18, No. 4 Printed in U.S.A. Antigenicity of Influenza Vaccine from Bovine Cell Cultures EDUARDO LEIDERMAN1
More information(From the Biological Department, Chemical Corps, Camp Derrick, Frederick, Maryland)
OBSERVATIONS ON THE AGGLUTINATION OF POLYSACCHARIDE- TREATED ERYTHROCYTES BY TULAREMIA ANTISERA B~ MARY M. ALEXANDER,* PH.D., GEORGE G. WRIGHT, PH.D., AND AGNES C. BALDWIN" (From the Biological Department,
More informationSTUDIES OF THE HEMAGGLUTININ OF HAEMOPHILUS PERTUSSIS HIDEO FUKUMI, HISASHI SHIMAZAKI, SADAO KOBAYASHI AND TATSUJI UCHIDA
STUDIES OF THE HEMAGGLUTININ OF HAEMOPHILUS PERTUSSIS HIDEO FUKUMI, HISASHI SHIMAZAKI, SADAO KOBAYASHI AND TATSUJI UCHIDA The National Institute of Health, Tokyo, Japan (Received: August 3rd, 1953) INTRODUCTION
More informationTHE CYTOPATHOGENIC ACTION OF BLUETONGUE VIRUS ON TISSUE CULTURES AND ITS APPLICATION TO THE DETECTION OF ANTIBODIES IN THE SERUM OF SHEEP.
Onderstepoort Journal of Veterinary Research, Volume 27, Number 2, October, 1956. The Government Printer. THE CYTOPATHOGENIC ACTION OF BLUETONGUE VIRUS ON TISSUE CULTURES AND ITS APPLICATION TO THE DETECTION
More informationThis product was developed by the Victorian Infectious Diseases Reference Laboratory (VIDRL) in its capacity as a WHO Collaborating Centre for
This product was developed by the Victorian Infectious Diseases Reference Laboratory (VIDRL) in its capacity as a WHO Collaborating Centre for Reference and Research on Influenza, with material provided
More informationThe Behaviour of Tanned Erythrocytes in Various Haemagglutination Systems
J. gen. Mimobiol. (1965), 38, 181-187 Printed in Great Britain 181 The Behaviour of Erythrocytes in Various Haemagglutination Systems BY G. A. GARABEDIAN Department of Bacteriology and Virology, American
More informationIsolation of Influenza C Virus from Pigs and Experimental Infection of Pigs with Influenza C Virus
J. gen. Virol. (1983), 64, 177-182. Printed in Great Britain 177 Key words: influenza C virus/antibodies/pigs Isolation of Influenza C Virus from Pigs and Experimental Infection of Pigs with Influenza
More informationBY F. BROWN, B. CARTWRIGHT AND DOREEN L. STEWART Research Institute (Animal Virus Diseases), Pirbright, Surrey. (Received 22 August 1962) SUMMARY
J. gen. Microbial. (1963), 31, 179186 Prinied in Great Britain 179 The Effect of Various Inactivating Agents on the Viral and Ribonucleic Acid Infectivities of FootandMouth Disease Virus and on its Attachment
More informationCytomegalovirus Based upon Enhanced Uptake of Neutral
JOURNAL OF CUNICAL MICROBIOLOGY, JUlY 1976, p. 61-66 Copyright 1976 American Society for Microbiology Vol. 4, No. 1 Printed in U.S.A. Plaque Reduction Neutralization Test for Human Cytomegalovirus Based
More informationConcentration and Purification of Influenza Virus on Insoluble Polyelectrolytes
APPEuw MicRoBIoLoGY, Apr. 1972, p. 740-744 Copyright 0 1972 American Society for Microbiology Vol. 23, No. 4 Printed in U.S.A. Concentration and Purification of Influenza Virus on Insoluble Polyelectrolytes
More informationReagents for the Typing of Human Influenza Isolates 2011
Reagents for the Typing of Human Influenza Isolates 2011 This product was developed by the Victorian Infectious Diseases Reference Laboratory (VIDRL) in its capacity as a WHO Collaborating Centre for Reference
More informationAmantadine in Tissue Culture'
JOURNAL OF BACTERIOLOGY, Sept., 1965 Copyright 1965 American Society for Microbiology Vol. 90, No. 3 Printed in U.S.A. Mode of Action of the Antiviral Activity of Amantadine in Tissue Culture' C. E. HOFFMANN,
More informationINTRABULBAR INOCULATION OF JAPANESE ENCEPHALITIS VIRUS TO MICE
THE KURUME MEDICAL JOURNAL Vol. 15, No. 1, 1968 INTRABULBAR INOCULATION OF JAPANESE ENCEPHALITIS VIRUS TO MICE TOSHINORI TSUCHIYA Department of Microbiology, and Department of Ophthalmology, Kurume University
More informationRole of Interferon in the Propagation of MM Virus in L Cells
APPLIED MICROBIOLOGY, Oct. 1969, p. 584-588 Copyright ( 1969 American Society for Microbiology Vol. 18, No. 4 Printed in U S A. Role of Interferon in the Propagation of MM Virus in L Cells DAVID J. GIRON
More informationInhibition of Virus Release by Antibodies to Surface Antigens of
JOURNAL OF VIROLOGY, Feb. 1974, P. 269-275 Copyright 0 1974 American Society for Microbiology Vol. 13, No. 2 Printed in U.S.A. Inhibition of Virus Release by Antibodies to Surface Antigens of Influenza
More informationC for 2 hr at 22,620 X G. The supernatant fluid. was discarded and the sediment resuspended to
SAFETY TEST FOR Q FEVER VACCINE SANFORD BERMAN, GERALD LE, JOSEPH P. LOWENTHAL, AND RAYMOND B. GOCHENOUR Department of Biologics Research, Division of Immunology, Walter Reed Army Institute of Research,
More informationTest Report. Efficacy of A New JM Nanocomposite Material in Inhibiting Respiratory Syncytial Virus Cellular Infection
Test Report Efficacy of A New JM Nanocomposite Material in Inhibiting Respiratory Syncytial Virus Cellular Infection Test Reagent New JM Nanocomposite Material Project Commissioner JM Material Technology,
More informationAn Immunological Study of Avian, Viral and Bacterial Neurarninidase Based on Specific Inhibition of Enzyme by Antibody
J. gen. Microbiol. (1963), 32, 225-233 Printed in Great Britain 225 An Immunological Study of Avian, Viral and Bacterial Neurarninidase Based on Specific Inhibition of Enzyme by Antibody BY G. L. ADA AND
More informationPandemic Preparedness Team Immunology and Pathogenesis Branch Influenza Division Centers for Disease Control and Prevention USA VERSION 1
MODIFIED HEMAGGLUTINATION INHIBITION (HI) ASSAY USING HORSE RBCS FOR SEROLOGIC DETECTION OF ANTIBODIES TO H7 SUBTYPE AVIAN INFLUENZA VIRUS IN HUMAN SERA Pandemic Preparedness Team Immunology and Pathogenesis
More informationRadioimmunoassay of Herpes Simplex Virus Antibody: Correlation with Ganglionic Infection
J. gen. Virol. (I977), 3 6, ~ 371-375 Printed in Great Britain 371 Radioimmunoassay of Herpes Simplex Virus Antibody: Correlation with Ganglionic Infection By B. FORGHANI, TONI KLASSEN AND J. R. BARINGER
More informationBrief Definitive Report
Brief Definitive Report HEMAGGLUTININ-SPECIFIC CYTOTOXIC T-CELL RESPONSE DURING INFLUENZA INFECTION BY FRANCIS A. ENNIS, W. JOHN MARTIN, ANY MARTHA W. VERBONITZ (From the Department of Health, Education
More informationNEUTRALIZATION OF VISNA VIRUS BY HUMAN SERA
THE ENTEROVIRUS DEPARTMENT, STATENS SERUMINSTITUT, COPENHAGEN, DENMARK NEUTRALIZATION OF VISNA VIRUS BY HUMAN SERA By HALLD~R THORMAR~ and HERDIS VON MACNUS Received 28.ix.62 In a previous paper (12) the
More informationSUSCEPTIBILITY OF SUCKLING MICE TO VARIOLA VIRUS
SUSCEPTIBILITY OF SUCKLING MICE TO VARIOLA VIRUS RONALD G. MARSHALL AND PETER J. GERONE U. S. Army Chemical Corps, Fort Detrick, Frederick, Maryland Received for publication December, 6 ABSTRACT MARSHALL,
More informationRecommended laboratory tests to identify influenza A/H5 virus in specimens from patients with an influenza-like illness
World Health Organization Recommended laboratory tests to identify influenza A/H5 virus in specimens from patients with an influenza-like illness General information Highly pathogenic avian influenza (HPAI)
More informationSubunits of Hemagglutinating Virus of Japan
JOURNAL OF VIROLOGY, OCt. 1970, p. 492-499 Vol. 6, No. 4 Copyright 1970 American Society for Microbiology Printed in U.S.A. Isolation of Hemagglutinin and Neuraminidase Subunits of Hemagglutinating Virus
More informationEffects of Tween 80 and Freon 113 on Measles Virus
Appiua MICROBIOLOGY, Mar. 1969, p. 379-383 Copyright 1969 American Society for Microbiology Vol. 17, No. 3 Printed in U.S.A. Effects of Tween 80 and Freon 113 on Measles Virus WOLF PARISIUS AND HILDA G.
More informationTesting Protocol Page 2 of 17 Table of Contents 1. Introduction 2. Materials 2.1 Equipment/instrumentation 2.2 Reagents/supplies 3. Preparation for th
Page 1 of 17 United States Department of Agriculture National Veterinary Services Laboratories Testing Protocol Hemagglutination-Inhibition Test for Subtype Identification of Date: June 1, 2005 Number:
More informationSOME PROPERTIES OF ECHO AND COXSACKIE VIRUSES IN TISSUE CULTURE AND VARIATIONS BY HEAT
THE KURUME MEDICAL JOURNAL Vol. 9, No. 1, 1962 SOME PROPERTIES OF ECHO AND COXSACKIE VIRUSES IN TISSUE CULTURE AND VARIATIONS BY HEAT SHIGERU YAMAMATO AND MASAHISA SHINGU Department of Microbiology, Kurume
More information(;[rowth Charaeteristies of Influenza Virus Type C in Avian Hosts
Archives of Virology 58, 349--353 (1978) Archives of Virology by Springer-Verlag 1978 (;[rowth Charaeteristies of Influena Virus Type C in Avian Hosts Brief Report By M ~R A~N D. AUSTIn, A. S. MONTO, and
More informationBlocking Interhost Transmission of Influenza Virus by Vaccination in the Guinea Pig Model
JOURNAL OF VIROLOGY, Apr. 2009, p. 2803 2818 Vol. 83, No. 7 0022-538X/09/$08.00 0 doi:10.1128/jvi.02424-08 Copyright 2009, American Society for Microbiology. All Rights Reserved. Blocking Interhost Transmission
More informationAntiviral Action of Mouse Interferon
JOURNAL OF BACTERIOLOGY, Jan., 1966 Copyright 1966 American Society for Microbiology Vol. 91, No. I Printed in U.S.A. Antiviral Action of Mouse Interferon in Heterologous Cells1 CHARLES E. BUCKLER AND
More information(From the Laboratories of the International Health Division of The Rockefeller Foundation, New York)
Published Online: 1 August, 1942 Supp Info: http://doi.org/10.1084/jem.76.2.195 Downloaded from jem.rupress.org on November 10, 2018 ADSORPTION OF INFLUENZA HEMAGGLUTININS AND VIRUS BY RED BLOOD CELLS
More information(From the Department of Epidemiology and Virus Laboratory, School of Pubbic Health, University of Michigan, Ann Arbor) Methods
Published Online: 1 November, 1948 Supp Info: http://doi.org/1.184/jem.88.5.515 Downloaded from jem.rupress.org on May 3, 218 THE RELATION OF INFECTIOUS AND HEMAGGLUTINATION TITERS TO THE ADAPTATION OF
More informationULOMA VENERUM GROUP AND HERPES SIMPLEX UNDER GIRARDI,1. Horsfall (1940) has shown that at -70 C most viruses retain their infectivity
PRESERVATION OF VIRUSES OF THE PSITTACOSIS-LYMPHOGRAN- ULOMA VENERUM GROUP AND HERPES SIMPLEX UNDER VARIOUS CONDITIONS OF STORAGE GIRARDI,1 EMMA G. ALLEN, BEN KANEDA, ANTHONY J. T. F. McNAIR SCOTT, AND
More informationThe Action of Normal Mouse Serum on Influenza Virus
CHU, C. M. (1951). J. gen. Microbiol. 5, 739-757. 739 The Action of Normal Mouse Serum on Influenza Virus BY C. M. CHU The World Influenza Centre, National Institute for Medical Research, London, N. W.7
More informationCross-Reactivity to Field Isolates of Canine Influenza Virus by a Killed Canine Influenza Virus (H3N8, Iowa05) Vaccine
Cross-Reactivity to Field Isolates of Canine Influenza Virus by a Killed Canine Influenza Virus (H3N8, Iowa05) Vaccine Nancee Oien, B.S., M.S. a Sally Mattern, B.S a Jaime Brozowski, B.S., M.S. b Janet
More informationHuman Influenza A (Swine Flu) Rapid test
Human Influenza A (Swine Flu) Rapid test Cat.No: DTSXY-Z9 Lot. No. (See product label) Size 20T Intended use The Influenza A (Swine Flu) test is a rapid chromatographic immunoassay for the qualitative
More informationTo detect antibodies to Avian Influenza (AI) using the haemagglutination inhibition test in avian serum specimens 2.
SADC Harmonized SOP for Avian Influenza HA and HI Serological Tests Prepared by: Dr. P.V. Makaya, Dr. Joule Kangumba and Ms Delille Wessels Reviewed by Dr. P.V. Makaya 1. Purpose and scope To detect antibodies
More informationREAGENTS FOR THE TYPING OF HUMAN INFLUENZA ISOLATES 2017
REAGENTS FOR THE TYPING OF HUMAN INFLUENZA ISOLATES 2017 This product was developed by the Victorian Infectious Diseases Reference Laboratory (VIDRL) in its capacity as a WHO Collaborating Centre for Reference
More informationAssay of Interferon Activity
Assay of Interferon Activity MXI. BALDUCCI, P. VERANI, AND D. BALDUCCI Department of Microbiology, Istituto Superiore di Sanita, Rlome, Italy Received for publication 2 January 1963 '4 ABSTRACT BALDUCCI,
More informationposed to high concentrations of the antigen for prolonged
THE DEMONSTRATION OF TYPE SPECIFIC STREPTOCOCCAL ANTIBODY BY A HEMAGGLUTINATION TECHNIQUE EMPLOYING TANNIC ACID 1 By FLOYD W. DENNY, JR., AND LEWIS THOMAS (From the Heart Hospital Research Laboratories,
More informationIssued by: LABORATORY MANAGER Original Date: March 20, 2000 Approved by: Laboratory Director Revision Date: July 26, 2000 CRYPTOCOCCAL ANTIGEN
Policy # MI\TECH\11\v01 Page 1 of 6 Issued by: LABORATORY MANAGER Original Date: March 20, 2000 Approved by: Laboratory Director Revision Date: July 26, 2000 CRYPTOCOCCAL ANTIGEN Latex particles coated
More informationAnimal model for testing human Ascaris allergens
J. Biosci., Vol. 3 Number 1, March 1981, pp. 77-82. Printed in India. Animal model for testing human Ascaris allergens KRISHNA MUKERJI*, R. P. SAXENA, S. N. GHATAK and K. C. SAXENA Division of Biochemistry,
More informationISOLATION OF ENTEROVIRUSES FROM THE "NORMAL" BABOON (PAPIO DOGUERA)l
ISOLATION OF ENTEROVIRUSES FROM THE "NORMAL" BABOON (PAPIO DOGUERA)l R. FUENTES-MARINS,2 A. R. RODRIGUEZ, S. S. KALTER, A. HELLMAN, AND R. A. CRANDELL The Southwest Foundation for Research and Education,
More informationIdentification of the Virucidal Agent in Wastewater Sludge
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, Apr. 1977, p. 860-864 Copyright X) 1977 American Society for Microbiology Vol. 33, No. 4 Printed in U.S.A. Identification of the Virucidal Agent in Wastewater Sludge
More informationTween-Ether-Treated Influenza Vaccine
APPLIED MICROBIOLOGY, OCt. 97, p. 544-55 Vol., No. 4 Copyright 97 American Society for Microbiology Printed in U.S.A. Enhanced Immunogenicity in Mice of a Purified, Tween-Ether-Treated Influenza Vaccine
More informationPlaque Assay of Sendai Virus in Monolayers of a Clonal Line
JOURNAL OF CUNICAL MICROBIOLOGY, Feb. 1976. p. 91-95 Copyright 1976 American Society for Microbiology Vol. 3, No. 2 Printed in U.SA. Plaque Assay of Sendai Virus in Monolayers of a Clonal Line of Porcine
More informationFreeze-Dried Erythrocytes for an Indirect Hemagglutination Test for Detection of Cytomegalovirus Antibodies
JOURNAL OF CLINICAL MICROBIOLOGY, June 1981, p. 1026-1030 0095-1 137/81/061026-05$02.00/0 Vol. 13, No. 6 Freeze-Dried Erythrocytes for an Indirect Hemagglutination Test for Detection of Cytomegalovirus
More informationCHEMICAL STUDIES ON BACTERIAL AGGLUTINATION II. THE IDENTITY OF PRECIPITIN AND AGGLUTININ* BY MICHAEL HEIDELBERGER, PH.D., AND ELVIN A.
CHEMICAL STUDIES ON BACTERIAL AGGLUTINATION II. THE IDENTITY OF PRECIPITIN AND AGGLUTININ* BY MICHAEL HEIDELBERGER, PH.D., AND ELVIN A. KABAT (From the Laboratories of the Departments of Medicine and Biological
More informationPERSISTENT INFECTIONS WITH HUMAN PARAINFLUENZAVIRUS TYPE 3 IN TWO CELL LINES
71 PERSISTENT INFECTIONS WITH HUMAN PARAINFLUENZAVIRUS TYPE 3 IN TWO CELL LINES Harold G. Jensen, Alan J. Parkinson, and L. Vernon Scott* Department of Microbiology & Immunology, University of Oklahoma
More informationQuantitative Assay of Paravaccinia Virus Based
APPrU MICROBIOLOGY, JUly 1972, p. 138-142 Copyright 1972 American Society for Microbiology Vol. 24, No. 1 Printed in U.S.A. Quantitative Assay of Paravaccinia Virus Based on Enumeration of Inclusion-Containing
More informationApplication of μmacs Streptavidin MicroBeads for the analysis of HIV-1 directly from patient plasma
Excerpt from MACS&more Vol 8 1/2004 Application of μmacs Streptavidin MicroBeads for the analysis of HIV-1 directly from patient plasma L. Davis Lupo and Salvatore T. Butera HIV and Retrovirology Branch,
More informationDRAFT. c 2.G Serological diagnosis of influenza by microneutralization assay 2.G
2.G c 2.G Serological diagnosis of influenza by microneutralization assay Serological methods rarely yield an early diagnosis of acute influenza virus infection. However, the demonstration of a significant
More informationSerological Studies of Types A, B, and E Botulinal Toxins by Passive Hemagglutination and Bentonite Flocculation
JOURNAL OF BACTERIOLOGY, Mar., 1966 Copyright 1966 American Society for Microbiology Vol. 91, No. Printed in U.S.A. Serological Studies of Types A, B, and E Botulinal Toxins by Passive Hemagglutination
More informationRubella Latex Agglutination Test
Rubella Latex Agglutination Test Cat. No.:DLAT1088 Pkg.Size:30T Intended use The Rubella Latex Agglutination Test is a rapid latex particle agglutination test for the qualitative and semi-quantitative
More informationFACTORS INFLUENCING VARIOLA VIRUS GROWTH ON THE CHORIOALLANTOIC MEMBRANE OF EMBRYONATED EGGS
FACTORS INFLUENCING VARIOLA VIRUS GROWTH ON THE CHORIOALLANTOIC MEMBRANE OF EMBRYONATED EGGS NICHOLAS HAHON, MILTON RATNER, AND EDMUND KOZIKOWSKI U. S. Army Chemical Corps, Fort Detrick, Frederick, Maryland
More informationSee external label 2 C-8 C = C-REACTIVE PROTEIN (CRP) LATEX SLIDE TEST
CORTEZ DIAGNOSTICS, INC. 21250 Califa Street, Suite 102 and 116, Woodland Hills, CA 91367 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com
More informationSimplex and Varicella-Zoster Virus Antigens in Vesicular
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1980, p. 651-655 0095-1137/80/11-0651/05$02.00/0 Vol. 12, No. 5 Direct Immunofluorescence Staining for Detection of Herpes Simplex and Varicella-Zoster Virus Antigens
More informationImmobilized Virions, and Mixed Hemadsorption
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 1977, p. 346-352 Copyright 1977 American Society for Microbiology Vol. 5, No. 3 Printed in U.S.A. New Tests for Characterization of Mumps Virus Antibodies: Hemolysis
More informationMechanism of Pock Formation by Shope Fibroma
JOURNAL OF BACTERIOLOGY, Sept., 1966 Copyright ( 1966 American Society for Microbiology Vol. 92, No. 3 Printed in U.S.A. Mechanism of Pock Formation by Shope Fibroma Virus on Monolayers of Rabbit Cells
More information(From the Department of Animal and Plant Pathology of The Rockefeller Institute for Medical Research, Princeton, New Jersey)
THE YIELD OF RABIES VIRUS IN THE CHICK EMBRYO BY BJORN SIGURDSSON, M.D.* (From the Department of Animal and Plant Pathology of The Rockefeller Institute for Medical Research, Princeton, New Jersey) (Received
More informationCharlottesville, Virginia. Michael, and Whitby, 1962), and the hemagglutination
SEROLOGICAL STUDIES OF 0 ANTIGENS OF ESCHERICHIA COLI BY MEANS OF THE HEMAGGLUTINATION TEST CALVIN M. KUNIN' AND MARY V. BEARD Departments of Preventive Medicine and Medicine, University of Virginia School
More informationStandardized Viral Hemagglutination and
APPLIED MICROBIOLOGY, Nov. 1969, p. 8-833 Vol. 18, No. 5 Copyright 1969 American Society for Microbiology Printed in U.S.A. Standardized Viral Hemagglutination and Hemagglutination-Inhibition Tests II.
More informationIn the Name of God. Talat Mokhtari-Azad Director of National Influenza Center
In the Name of God Overview of influenza laboratory diagnostic technology: advantages and disadvantages of each test available Talat Mokhtari-Azad Director of National Influenza Center Tehran- Iran 1 1)
More informationDetection of Foot-and-Mouth Disease Virus Antibodies
APPUED MICROBIOLOGY, July 1970, p. 35-39 Copyright 1970 American Society for Microbiology Vol. 20, No. 1 Printed in U.S.A. Detection of Foot-and-Mouth Disease Virus Antibodies I. "Passive" Hemagglutination
More informationRapid-VIDITEST Swine Flu
Rapid-VIDITEST Swine Flu One Step Influenza type A Antigen Card test. Instruction manual Producer: VIDIA spol. s r.o., Nad Safinou II 365, 252 50 Vestec, Czech Republic, Tel.: +420 261 090 565, www.vidia.cz
More informationEffect of Vaccine, Route, and Schedule on Antibody
APPUED MICROBIOLOGY, Mar. 1969, p. 355-359 Copyright 1969 American Society for Microbiology Vol. 17, No. 3 Printed in U.S.A. Effect of Vaccine, Route, and Schedule on Antibody Response of Rabbits to Pasteurella
More informationHaemagglutination by Bovine Leukaemia Virus
J. gen. Virol. (1982), 59, 83-89. Printed in Great Britain 83 Key words: BL V/glycoprotein/haemagglutination/retrovirus Haemagglutination by Bovine Leukaemia Virus By HIROSHI SENTSUI,I*t RICHARD M. THORN,
More informationCOAGULATION OF HUMAN PLASMA BY PASTEURELLA PESTIS'
COAGULATION OF HUMAN PLASMA BY PASTEURELLA PESTIS' DANIEL M. EISLER Naval Biological Laboratory, School of Public Health, University of California, Berkeley, California Received for publication June 27,
More informationAn evaluation of two new haemagglutination tests for the rapid diagnosis of autoimmune thyroid diseases
Journal of Clinical Pathology, 1978, 31, 1147-115 An evaluation of two new haemagglutination tests for the rapid diagnosis of autoimmune thyroid diseases I. CAYZER, S. R. CHALMERS, D. DONIACH', AND G.
More informationG. W. WOOD J. C. MUSKETT and D. H. THORNTON MAFF, Central Veterinary Laboratory, New Haw, Weybridge, Surrey, U.K.
J. Comp. Path. 1986 vol. 96 OBSERVATIONS ON THE ABILITY OF AVIAN REOVIRUS VACCINMATION OF HENS TO PROTECT THEIR PROGENY AGAINST THE EFFECTS OF CHALLENGE WITH HOMOLOGOUS AND HETEROLOGOUS STRAINS By G. W.
More informationAperto Cell Lysis and Protein Solubilization Users Manual
Aperto Cell Lysis and Protein Solubilization Users Manual Revision 2 THIS MANUAL APPLIES TO THE FOLLOWING PRODUCTS: 3A8600 Aperto, 5X Cell Lysis Buffer. 20mL 3A8610 Aperto, 5X Cell Lysis Buffer. 100mL
More informationPreparation of La Crosse Virus Hemagglutinating
APPLIED MICROBIOLOGY, Sept. 1969, p. 33-37 Copyright 1969 American Society for Microbiology Vol. 18, No. 3 Printed in U.S.A. Preparation of La Crosse Virus Hemagglutinating Antigen in BHK-21 Suspension
More informationPRODUCT INFORMATION & MANUAL
PRODUCT INFORMATION & MANUAL 0.4 micron for Overall Exosome Isolation (Cell Media) NBP2-49826 For research use only. Not for diagnostic or therapeutic procedures. www.novusbio.com - P: 303.730.1950 - P:
More informationSensoLyte pnpp Alkaline Phosphatase Assay Kit *Colorimetric*
SensoLyte pnpp Alkaline Phosphatase Assay Kit *Colorimetric* Catalog # 72146 Kit Size 500 Assays (96-well plate) Optimized Performance: This kit is optimized to detect alkaline phosphatase activity Enhanced
More informationINFLUENZA EVOLUTION: Challenges for diagnosis
INFLUENZA EVOLUTION: Challenges for diagnosis Jairo A. Méndez-Rico Influenza Team PAHO/WHO, Washington, DC Overview Every year, influenza infects up to one in five people around the world, and causes up
More informationEVALUATION OF THE EFFECTIVENESS OF A 7% ACCELERATED HYDROGEN PEROXIDE-BASED FORMULATION AGAINST CANINE PARVOVIRUS
Final report submitted to Virox Technologies, Inc. EVALUATION OF THE EFFECTIVENESS OF A 7% ACCELERATED HYDROGEN PEROXIDE-BASED FORMULATION AGAINST CANINE PARVOVIRUS Syed A. Sattar, M.Sc., Dip. Bact., M.S.,
More information(From the Hospital of The Rockefeller Institute for Medical Research)
THE ASSOCIATIVE REACTIONS OF PNEUMONIA VIRUS OF MICE (PVM) AND INFLUENZA VIRUSES: THE EFFECTS OF ph AND ELECTROLYTES UPON VIRUS-HOST CELL COMBINATIONS BY FRED M, DAVENPORT, M.D.,*, :]: AI~ID FRANK L. HORSFALL,
More informationCryptococcal Antigen Latex Agglutination Test
Cryptococcal Antigen Latex Agglutination Test Cat. No.:DLAT1109 Pkg.Size:100T Intended use The Cryptococcal Antigen Latex Agglutination Test is a simple and rapid latex agglutination test for the qualitative
More informationE.Z.N.A. SQ Blood DNA Kit II. Table of Contents
E.Z.N.A. SQ Blood DNA Kit II Table of Contents Introduction and Overview...2 Kit Contents/Storage and Stability...3 Blood Storage and DNA Yield...4 Preparing Reagents...5 100-500 μl Whole Blood Protocol...6
More informationBSII Lectin: A Second Hemagglutinin Isolated from Bandeiraea Simplicifolia Seeds with Afiinity for type I11 Polyagglutinable Red Cells
Vox Sang. 33: 46-51 (1977) BSII Lectin: A Second Hemagglutinin Isolated from Bandeiraea Simplicifolia Seeds with Afiinity for type I11 Polyagglutinable Red Cells W. J. Judd, M. L. Beck, B. L. Hicklin,
More informationChronic Infections by Herpes Simplex Viruses and by the Horse and Cat Herpesviruses
INFECTION AND IMMUNITY, Apr. 70, p. 351-355 Copyright 70 American Society for Microbiology Vol. 1, No. 4 Printed in U.S.A. Chronic Infections by Herpes Simplex Viruses and by the Horse and Cat Herpesviruses
More informationInfluenza or flu is a
Clinical and Research Area Infectious Diseases Influenza Virus Types A and B Influenza or flu is a respiratory illness that is caused by influenza viruses. Influenza viruses type A and type B cause seasonal
More informationEXPERIMENTAL SALMONELLOSIS
EXPERIMENTAL SALMONELLOSIS INTRACELLULAR GROWTH OF Salmonella enteritidis INGESTED IN MONONUCLEAR PHAGOCYTES OF MICE, AND CELLULAR BASIS OF IMMUNITY SUSUMU MITSUHASHI, ICHIEI SATO, AND TOKUMITSU TANAKA
More informationDetection of Antibodies to Epstein-Barr Virus Capsid Antigen
JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 1982, p. 69-73 95-1137/82/169-5$2./ Vol. 15, No.1 Detection of Antibodies to Epstein-Barr Virus Capsid Antigen by Immune Adherence Hemagglutination EVELYNE T. LENNETTE,t
More informationChlorphenesin: an Antigen-Associated Immunosuppressant
INFECTION AND IMMUNITY, JUlY 197, p. 6-64 Vol. 2, No. 1 Copyright 197 American Society for Microbiology Printed in U.S.A. Chlorphenesin: an Antigen-Associated Immunosuppressant H. Y. WHANG AND E. NETER
More informationIsolation and Characterization of Defective. Disease Virus
Microbiol. Immunol. Vol. 22 (12), 775-784, 1978 Isolation and Characterization of Defective Interfering Particle of Newcastle Disease Virus Akitoshi MAEDA,1 Yasuo SUZUKI, and Makoto MATSUMOTO Department
More informationThe Action of Protease on Influenza Az Virus
Y. gen. Virol 0968), z, 19-28 With z plates Printed in Great Britah7 I9 The Action of Protease on Influenza Az Virus By F. BIDDLE University College Hospital Medical School, Department of Bacteriology,
More informationRecipes for Media and Solution Preparation SC-ura/Glucose Agar Dishes (20mL/dish, enough for 8 clones)
Protocol: 300 ml Yeast culture preparation Equipment and Reagents needed: Autoclaved toothpicks Shaker Incubator set at 30 C Incubator set at 30 C 60 mm 2 sterile petri dishes Autoclaved glass test tubes
More informationSTUDIES ON HOST-VIRUS INTERACTIONS IN THE CHICK.: EMBRYO-INFLUENZA VIRUS SYSTEM*
STUDIES ON HOST-VIRUS INTERACTIONS IN THE CHICK.: EMBRYO-INFLUENZA VIRUS SYSTEM* IlL DEVELOPMENT OF INFECTIVITY, HEMAGGLUTINATION, AND COMPLEMENT FIXATION ACTIVITIES DURING THE FIRST INFECTIOUS CYCLE Bx
More informationCELLULAR KINETICS OF THE ANTI-MRBC RESPONSE IN CHICKENS
19 CELLULAR KINETICS OF THE ANTI-MRBC RESPONSE IN CHICKENS K. Dagg, S. P. Turner and F. Seto Department of Zoology, University of Oklahoma, Norman, Oklahoma The serum hemagglutinin (HA) titers and the
More informationIMMUNOLOGIC REACTIVITY IN HUMAN BREAST CANCER AGAINST CULTURED HUMAN BREAST TUMOR CELLS
22 IMMUNOLOGIC REACTIVITY IN HUMAN BREAST CANCER AGAINST CULTURED HUMAN BREAST TUMOR CELLS Michael P. Lerner*, J. H. Anglin, Peggy L. Munson, Peggy J. Riggs, Nancy E. Manning, and Robert E. Nordquist Departments
More informationIVD information *Droppers for the sensitized and control cells. Not for use other than dispensing the sensitized and control cells.
In Vitro Diagnostic Reagent Instruction Manual of Diagnostic Reagent for Determination of anti-hbs Thoroughly read this instruction manual before use of this kit Background of the development and features
More information